AFR vs Somalia: Hepatitis B surface antigen (HBsAg) prevalence
AFR
1.4%
in 2024
Somalia
4.0%
in 2024
AFR rank
1st
Somalia rank
2nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- AFR
- Somalia
How they compare
Somalia currently reports 4.0% against 1.4% in AFR, a difference of 2.6%.
That makes Somalia's figure about 2.9 times AFR's.
Across all 10 years both countries report, Somalia has been ahead every year.
AFR ranks 1st and Somalia ranks 2nd of 7 groups.
Somalia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | AFR | Somalia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.9% | 6.4% | 4.5% | Somalia |
| 2020s | 1.6% | 4.4% | 2.9% | Somalia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, AFR or Somalia?
- Somalia, at 4.0% against 1.4% in AFR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between AFR and Somalia?
- 2.6%, with Somalia ahead.
- How many years of comparable data are there for AFR and Somalia?
- 10 years are reported by both, from 2015 to 2024.
- How do AFR and Somalia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- AFR ranks 1st and Somalia ranks 2nd of 7 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.